Document is current

Any future updates will be listed below

Data driven polypharmacological drug design for lung cancer: analyses for targeting ALK, MET, and EGFR

Crossref DOI link: https://doi.org/10.1186/s13321-017-0229-8

Published Online: 2017-07-04

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark